CUAMC

China Universal Asset Management Company Portfolio holdings

AUM $1.06B
This Quarter Return
-0.32%
1 Year Return
+31.81%
3 Year Return
+205.04%
5 Year Return
10 Year Return
AUM
$238M
AUM Growth
+$238M
Cap. Flow
+$26.9M
Cap. Flow %
11.34%
Top 10 Hldgs %
35.07%
Holding
478
New
384
Increased
35
Reduced
29
Closed
12

Top Sells

1
ZTO icon
ZTO Express
ZTO
$5.15M
2
JD icon
JD.com
JD
$4.92M
3
EDU icon
New Oriental
EDU
$4.58M
4
LI icon
Li Auto
LI
$4.43M
5
NTES icon
NetEase
NTES
$3.29M

Sector Composition

1 Technology 36.45%
2 Consumer Discretionary 23.79%
3 Healthcare 23.76%
4 Communication Services 3.6%
5 Consumer Staples 3.15%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
REPL icon
226
Replimune Group
REPL
$422M
$8K ﹤0.01%
+462
New +$8K
RNA icon
227
Avidity Biosciences
RNA
$5.99B
$8K ﹤0.01%
+488
New +$8K
AVXL icon
228
Anavex Life Sciences
AVXL
$828M
$8K ﹤0.01%
+730
New +$8K
EDIT icon
229
Editas Medicine
EDIT
$231M
$8K ﹤0.01%
+644
New +$8K
ALEC icon
230
Alector
ALEC
$238M
$7K ﹤0.01%
+773
New +$7K
ANAB icon
231
AnaptysBio
ANAB
$569M
$7K ﹤0.01%
+265
New +$7K
CHRS icon
232
Coherus Oncology, Inc. Common Stock
CHRS
$135M
$7K ﹤0.01%
+728
New +$7K
MCRB icon
233
Seres Therapeutics
MCRB
$166M
$7K ﹤0.01%
+1,162
New +$7K
MIRM icon
234
Mirum Pharmaceuticals
MIRM
$3.71B
$7K ﹤0.01%
+345
New +$7K
MNKD icon
235
MannKind Corp
MNKD
$1.41B
$7K ﹤0.01%
+2,410
New +$7K
RAPT icon
236
RAPT Therapeutics
RAPT
$188M
$7K ﹤0.01%
+278
New +$7K
SGMO icon
237
Sangamo Therapeutics
SGMO
$157M
$7K ﹤0.01%
+1,466
New +$7K
SIGA icon
238
SIGA Technologies
SIGA
$601M
$7K ﹤0.01%
+683
New +$7K
TBPH icon
239
Theravance Biopharma
TBPH
$699M
$7K ﹤0.01%
+716
New +$7K
KLRS
240
Kalaris Therapeutics, Inc. Common Stock
KLRS
$76.3M
$7K ﹤0.01%
+871
New +$7K
ME
241
DELISTED
23andMe Holding Co. Class A Common Stock
ME
$7K ﹤0.01%
+2,432
New +$7K
RETA
242
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$7K ﹤0.01%
+295
New +$7K
AERI
243
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
$7K ﹤0.01%
+463
New +$7K
INBX
244
DELISTED
Inhibrx, Inc. Common Stock
INBX
$7K ﹤0.01%
+365
New +$7K
ALT icon
245
Altimmune
ALT
$338M
$6K ﹤0.01%
+459
New +$6K
BCYC
246
Bicycle Therapeutics
BCYC
$511M
$6K ﹤0.01%
+239
New +$6K
CRBU icon
247
Caribou Biosciences
CRBU
$174M
$6K ﹤0.01%
+570
New +$6K
CSTL icon
248
Castle Biosciences
CSTL
$696M
$6K ﹤0.01%
+246
New +$6K
DYN icon
249
Dyne Therapeutics
DYN
$1.92B
$6K ﹤0.01%
+484
New +$6K
GLPG icon
250
Galapagos
GLPG
$2.07B
$6K ﹤0.01%
+132
New +$6K